相关实验视频
Updated: Jul 10, 2025
05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
177
人工智能用于诊断神经退行性疾病的应用
1School of Medicine, The Chinese University of Hong Kong (Shenzhen), Shenzhen, 518000, China.
Studies in health technology and informatics
|November 26, 2023
概括
人工智能 (AI) 通过分析大数据来增强神经退行性疾病的诊断. 机器学习和NLP等人工智能方法可以改善早期检测和预测阿尔茨海默氏症等疾病的患者结果.
科学领域:
- 神经科学是一个神经科学.
- 计算机科学 计算机科学
- 生物医学工程 生物医学工程
背景情况:
- 神经退行性疾病对全球健康构成重大挑战.
- 早期和准确的诊断对于有效的管理和治疗至关重要.
- 大数据时代在分析复杂的生物信息方面提供了机遇和挑战.
结论:
- 人工智能在改变神经退行性疾病的诊断和管理方面显示出重大前景.
- 基于人工智能的方法为改善患者的治疗结果提供了潜在的好处.
- 人工智能实施的挑战需要仔细考虑,以便广泛采用.
相关概念视频
01:26Alzheimer's Disease: Overview
494
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195